MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Cancer Treatment and Pharmacology
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,351 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,351 works in the cohort · of 4,299,418page 10 of 28

Labels cover 6 of 1,351 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,351 of 1,351 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Phase II study of PX-866 in recurrent glioblastoma.
Marshall Pitz, Elizabeth A. Eisenhauer, Mary MacNeil, Brian Thiessen, David Macdonald, Jacob C. Easaw +8 more
2013· article· en· Journal of Clinical Oncology· Medicine
machine prediction:candidate · noneconsensus · none
6
citations
affno abstractunlabeled
A new taxane from Taxus canadensis needles
Manli Zhang, Zhi‐Yu Ni, Yufang Wang, Mei Dong, Ligeng Li, Françoise Sauriol +3 more
2012· article· en· Chemistry of Natural Compounds· Medicine
machine prediction:candidate · noneconsensus · none
5
citations
fundno affno abstractunlabeled
349TiP EPIK-B3: A phase III, randomised, double-blind (DB), placebo (PBO)-controlled study of alpelisib (ALP) + nab-paclitaxel (nab-PTX) in advanced triple-negative breast cancer (TNBC) with either PIK3CA mutation or phosphatase and tensin homolog (PTEN) loss without PIK3CA mutation
Priyanka Sharma, Azeez Farooki, Peter A. Fasching, Sherene Loi, Kevin Peterson, Aleix Prat +7 more
2020· article· en· Annals of Oncology· Medicine
machine prediction:candidate · noneconsensus · none
5
citations
aboutno affunlabeled
CCCma CanESM5 model output prepared for CMIP6 DAMIP
Neil C. Swart, Jason N. S. Cole, Viatcheslav Kharin, Mike Lazare, John Scinocca, Nathan P. Gillett +14 more
2019· dataset· en· Earth System Grid Federation· Medicine
machine prediction:candidate · noneconsensus · none
5
citations
fundvenueaboutno affunlabeled
Canadensenes: Natural and semi-synthetic analogues
Qing‐Wen Shi, Anastasia Nikolakakis, Françoise Sauriol, Orval Mamer, Lolita O. Zamir
2003· article· en· Canadian Journal of Chemistry· Medicine
machine prediction:candidate · noneconsensus · none
5
citations

How this was built: Screen · Findings · About